Ketoconazole, Hydrocortisone, and GM-CSF in Treating Patients With Progressive Prostate Cancer After Hormone Therapy

NCT00309894 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

49

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

BIOLOGICAL: sargramostim
DRUG: ketoconazole
DRUG: therapeutic hydrocortisone

Sponsor

University of California, San Francisco

Collaborators

[object Object]